Skip to main content

Table 5 Schedule of research assessments for patient-participants

From: Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-feasibility study

Assessment

Screening

Baseline

Day 30

Eligibility and enrollment

Verbal consent

X

  

Prisoner status assessment

X

  

Demographics

X

  

Eligibility summary

X

  

Enrollment (inclusion/exclusion)

X

  

General

Written informed consent and medical release

X

  

Additional demographics

 

X

 

Locator information form

 

X

X

DSM-5 checklist for OUD

 

X

 

Other substance use [21]

 

X

 

EuroQol-5 dimensions (EQ-5D) [22]

 

X

X

Motivations, attitudes and expectations

 

X

 

Study completion

  

X

Health services

Inpatient utilization

 

X

X

Outpatient utilization

 

X

X

Health status [23,24,25]

 

X

X

Healthcare visit logistics

 

X

 

ED visit review

 

X

 

ED visits and hospitalizations

  

X

Process outcomes

Engagement in treatment

  

X

Prescription drug monitoring

  

X

Treatment decision

 

X

 

Treatment satisfaction/acceptability

  

X

Opioid outcomes

Timeline follow-back, 7-day (TLFB) [26, 27]

 

X

X

Urine drug screen

 

X

X

Overdose events and risk factors

 

X

X

Safety

Safety events

 

X

X